Featured
Press Releases
EvergreenHealth Implements UV Technology to Help Fight Infection-Causing Pathogens, Enhancing Hospital Safety
As part of its ongoing commitment to patient safety, EvergreenHealth has partnered with Clorox Healthcare to bring advanced ultraviolet light disinfecting technology to the health...
News
UK’s First Varian Halcyon Cancer Treatment Systems Scheduled for Queen’s Hospital
Cancer patients in the U.K. will gain access to the country’s first Varian Halcyon™ radiotherapy treatment devices when the first of two systems are delivered...
Research Insight
The Parker Institute and Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy
The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute announced the first patients have begun treatment in a new pancreatic cancer multi-center clinical trial....
News
InterVapor Bronchoscopic Thermal Vapor Ablation (BTVA) is Back on the Market
The InterVapor® Bronchoscopic Thermal Vapor Ablation (BTVA®) is back on the market after a brief hiatus as the asset sale of Uptake Medical Corporation was...
News
Cardiac SPECT solution at the American Society of Nuclear Cardiology’s Annual Scientific Session launched by Philips
Royal Philips , a global leader in health technology, today announced its presence at the American Society of Nuclear Cardiology’s Annual Scientific Session in Kansas...
Industry Reports
NuVasive announces acquisition of Vertera spine medical device company
NuVasive, Inc. , a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced the acquisition of Vertera Spine, a...
News
Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah
Novartis announced that the US FDA has approved Kymriah™(tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.